We're hiring! Fantastic opportunity to work with @JoeCursons and our Computational Biology and Bioinformatics team to support our IO target discovery efforts. Applications close Monday 2 November 2020, 11:55pm AEDT.
Momentum is building in the allogenic CAR cell therapy space with CAR NK cells receiving a lot of attention @GileadSciences @KitePharma CSO comments on NK cell therapies in cancer via their partnership with @oNKo_innate
With our deep understanding of Natural Killer (NK) cells, we aim to be the first to master NK cell biology and therapeutically harness the cancer-fighting abilities of these remarkable white blood cells.